Vertex Pharmaceuticals Inc (VRTX)
400.73
-3.88
(-0.96%)
USD |
NASDAQ |
Apr 24, 16:00
400.73
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash from Operations (TTM): 3.537B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.537B |
| September 30, 2023 | 4.381B |
| June 30, 2023 | 4.068B |
| March 31, 2023 | 4.074B |
| December 31, 2022 | 4.130B |
| September 30, 2022 | 4.046B |
| June 30, 2022 | 4.018B |
| March 31, 2022 | 2.679B |
| December 31, 2021 | 2.644B |
| September 30, 2021 | 2.140B |
| June 30, 2021 | 2.121B |
| March 31, 2021 | 3.359B |
| December 31, 2020 | 3.254B |
| September 30, 2020 | 3.208B |
| June 30, 2020 | 2.635B |
| March 31, 2020 | 2.060B |
| December 31, 2019 | 1.569B |
| September 30, 2019 | 1.438B |
| June 30, 2019 | 1.484B |
| March 31, 2019 | 1.342B |
| December 31, 2018 | 1.270B |
| September 30, 2018 | 1.183B |
| June 30, 2018 | 971.96M |
| March 31, 2018 | 831.91M |
| December 31, 2017 | 844.94M |
| Date | Value |
|---|---|
| September 30, 2017 | 762.16M |
| June 30, 2017 | 657.72M |
| March 31, 2017 | 516.93M |
| December 31, 2016 | 236.10M |
| September 30, 2016 | 120.52M |
| June 30, 2016 | -7.207M |
| March 31, 2016 | -158.33M |
| December 31, 2015 | -365.43M |
| September 30, 2015 | -576.36M |
| June 30, 2015 | -601.93M |
| March 31, 2015 | -619.59M |
| December 31, 2014 | -573.11M |
| September 30, 2014 | -371.57M |
| June 30, 2014 | -297.64M |
| March 31, 2014 | -170.65M |
| December 31, 2013 | -60.67M |
| September 30, 2013 | -39.87M |
| June 30, 2013 | 79.82M |
| March 31, 2013 | 199.15M |
| December 31, 2012 | 267.84M |
| September 30, 2012 | 730.94M |
| June 30, 2012 | 667.88M |
| March 31, 2012 | 333.28M |
| December 31, 2011 | 143.74M |
| September 30, 2011 | -526.03M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
1.438B
Minimum
Sep 2019
4.381B
Maximum
Sep 2023
2.992B
Average
3.208B
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Amgen Inc | 8.471B |
| Eli Lilly and Co | 4.240B |
| Regeneron Pharmaceuticals Inc | 4.594B |
| Alpine Immune Sciences Inc | -79.01M |
| Moderna Inc | -3.118B |